Cipla hit with 29 EPS cuts in 7 days as current-quarter estimate collapses 18%
India's Cipla (CIPLA.BO) received 29 downward EPS revisions in the last 7 days for its current-year estimate — the most of any healthcare name in the dataset this week. The current-quarter EPS consensus has been slashed 18% in 7 days (₹13.47 → ₹11.05) and the current-year estimate cut 12.6% in 30 days (₹60.07 → ₹52.51), while the stock has already fallen ~8.9% from its March 1 close.
Supporting 8 queries
To surface this insight, Baselight ran 8 queries across its structured data. Each one is reproducible — open it, read the SQL, and rerun it yourself.
Conclusion
Down_last_7_days: 29 (current year), 1 (next year) — eps_revisions snapshot Apr 17. Current-quarter EPS: ₹11.05 now vs ₹13.47 seven days ago (–18%). Current-year EPS: ₹52.51 now vs ₹60.07 thirty days ago (–12.6%). Current-year growth estimate: –19.5% vs sector index +17.6%. Stock close Apr 15: ₹1,230.5 vs Mar 1 close ₹1,351.6 (–8.9%).